VAPO
Undervalued by 200.5% based on the discounted cash flow analysis.
Market cap | $0.00 |
---|---|
Enterprise Value | $90.01 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-13.11 |
Beta | 0.0 |
Outstanding Shares | 6,211,674 |
Avg 30 Day Volume | 0 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 0.0 |
---|---|
PEG | -0.0 |
Price to Sales | 0.13 |
Price to Book Ratio | -0.16 |
Enterprise Value to Revenue | 1.33 |
Enterprise Value to EBIT | -1.85 |
Enterprise Value to Net Income | -2 |
Total Debt to Enterprise | 1.16 |
Debt to Equity | -2.2 |
No data
No data
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chro...